Skip to main content
Log in

miR-137/ERRα axis mediates chemoresistance of nasopharyngeal carcinoma cells

  • Research Article
  • Published:
Journal of Cell Communication and Signaling Aims and scope

Abstract

Nasopharyngeal carcinoma (NPC) is the most common malignant tumor of the head and neck region and is characterized by an increased risk of developing chemoresistance after treatment. The present study demonstrated that estrogen-related receptor α (ERRα) was upregulated in cisplatin- and fluorouracil-resistant NPC cells. In addition, ERRα knockdown or treatment of cells with the ERRα inverse agonist XCT-790 attenuated the chemoresistance of NPC cells. Mechanistically, the increased expression of ERRα in chemoresistant cells was associated with enhanced mRNA stability. Bioinformatics analysis for screening microRNAs (miRs) regulating the expression of ERRα revealed that miR-137 was downregulated in chemoresistant NPC cells. Additionally, transfection of cells with miR-137 mimics reduced ERRα mRNA stability and increased the chemosensitivity of NPC cells. Furthermore, ERRα knockdown reduced glucose consumption, and lactate and ATP production rates in chemoresistant cells. The aforementioned findings suggested that the miR-137/ERRα-mediated metabolic programming could be involved in the chemoresistance of NPC cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Availability of data and material

All data and material are available.

References

  • Ablashi DV, Levine PH, Prasad U, Pearson GR (1983) Fourth international symposium on nasopharyngeal carcinoma application of field and laboratory studies to the control of NPC. Cancer Res 43:2375–2378

    CAS  PubMed  Google Scholar 

  • Ao A, Wang H, Kamarajugadda S, Lu J (2008) Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA 105:7821–7826

    Article  CAS  Google Scholar 

  • Ariazi EA, Clark GM, Mertz JE (2002) Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 62:6510–6518

    CAS  PubMed  Google Scholar 

  • Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A (2010) Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 70:6609–6618

    Article  CAS  Google Scholar 

  • Cao SM, Simons MJ, Qian CN (2011) The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 30:114–119

    Article  CAS  Google Scholar 

  • Chen QJ, Chen XB, Zhang MZ, Fan QX, Luo SX, Cao XG (2011) miR-137 Is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Digest Dis Sci 56:2009–2016

    Article  CAS  Google Scholar 

  • Chen, P., Wang, H., Duan, Z., Zou, J. X., Chen, H., He, W., and Wang, J. (2014a). Estrogen-related receptor alpha confers methotrexate resistance via attenuation of reactive oxygen species production and P53 mediated apoptosis in osteosarcoma cells. Biomed Res Int 2014, 616025.

  • Chen P, Wang HB, Duan ZJ, Zou JX, Chen HW, He W, Wang JJ (2014b) Estrogen-related receptor alpha confers Methotrexate resistance via attenuation of reactive oxygen species production and p53 apoptosis pathway in osteosarcoma U2OS cells. J Bone Miner Res 29:S142–S142

    Article  Google Scholar 

  • Chen Y, Zhang K, Li Y, Guo R, Zhang K, Zhong G, He Q (2019a) Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1. J Cell Mol Med 23:2115–2124

    Article  CAS  Google Scholar 

  • Chen Y, Zhao H, Li H, Feng X, Tang H, Zhang J, Fu B, Qiu C (2019b) LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells. Mol Ther Nucleic Acids 19:168–178

    Article  Google Scholar 

  • Chen Y, Zhou Y, Han F, Zhao Y, Tu M, Wang Y, Huang C, Fan S, Chen P, Yao X et al (2020) A novel miR-1291-ERRalpha-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis. Theranostics 10:7193–7210

    Article  CAS  Google Scholar 

  • Cheng SQ, Huang YX, Lou C, He YX, Zhang Y, Zhang QY (2019) FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin beta 3/Wnt signaling under miR-137 regulation. Cancer Biol Ther 20:328–337

    Article  CAS  Google Scholar 

  • Deblois G, Smith HW, Tam IS, Gravel SP, Caron M, Savage P, Labbe DP, Begin LR, Tremblay ML, Park M et al (2016) ERRalpha mediates metabolic adaptations driving lapatinib resistance in breast cancer. Nat Commun 7:12156

    Article  CAS  Google Scholar 

  • Du FY, Yu L, Wu Y, Wang SQ, Yao J, Zheng XX, Xie SZ, Zhang SF, Lu XM, Liu Y, Chen W (2019) miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4. Cell Death Dis. https://doi.org/10.1038/s41419-019-2164-2

    Article  PubMed  PubMed Central  Google Scholar 

  • Fradet A, Sorel H, Bouazza L, Goehrig D, Depalle B, Bellahcene A, Castronovo V, Follet H, Descotes F, Aubin JE et al (2011) Dual function of ERRalpha in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Res 71:5728–5738

    Article  CAS  Google Scholar 

  • Fujimoto J, Sato E (2009) Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers. J Steroid Biochem Mol Biol 116:71–75

    Article  CAS  Google Scholar 

  • Fujimoto J, Alam SM, Jahan I, Sato E, Sakaguchi H, Tamaya T (2007) Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers. J Steroid Biochem Mol Biol 104:301–304

    Article  CAS  Google Scholar 

  • Giguere V, Yang N, Segui P, Evans RM (1988) Identification of a new class of steroid hormone receptors. Nature 331:91–94

    Article  CAS  Google Scholar 

  • Han L, Liu B, Jiang L, Liu J, Han S (2016) MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha. Tumour Biol 37:13205–13214

    Article  CAS  Google Scholar 

  • Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59

    Article  CAS  Google Scholar 

  • Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13:714–726

    Article  CAS  Google Scholar 

  • Huang C, Wu M, Tang Y, Li X, Ouyang J, Xiao L, Li D, Li G (2009) NAG7 promotes human nasopharyngeal carcinoma invasion through inhibition of estrogen receptor alpha and up-regulation of JNK2/AP-1/MMP1 pathways. J Cell Physiol 221:394–401

    Article  CAS  Google Scholar 

  • Huang H, Li J, Shen J, Lin L, Wu X, Xiang S, Li Y, Xu Y, Zhao Q, Zhao Y et al (2020) Increased ABCC4 expression induced by ERRalpha leads to docetaxel resistance via efflux of docetaxel in prostate cancer. Front Oncol 10:1474

    Article  Google Scholar 

  • Ji HL, Song CC, Li YF, He JJ, Li YL, Zheng XL, Yang GS (2014) miR-125a inhibits porcine preadipocytes differentiation by targeting ERRalpha. Mol Cell Biochem 395:155–165

    Article  CAS  Google Scholar 

  • Kozaki KI, Imoto I, Mogi S, Omura K, Inazawa J (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68:2094–2105

    Article  CAS  Google Scholar 

  • Lafargue A, Degorre C, Corre I, Alves-Guerra MC, Gaugler MH, Vallette F, Pecqueur C, Paris F (2017) Ionizing radiation induces long-term senescence in endothelial cells through mitochondrial respiratory complex II dysfunction and superoxide generation. Free Radical Biol Med 108:750–759

    Article  CAS  Google Scholar 

  • Lee AW, Ma BB, Ng WT, Chan AT (2015) Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol 33:3356–3364

    Article  Google Scholar 

  • Lukey MJ, Katt WP, Cerione RA (2018) Targeting therapy resistance: when glutamine catabolism becomes essential. Cancer Cell 33:795–797

    Article  CAS  Google Scholar 

  • Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguere V (2003) Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol Cell Biol 23:7947–7956

    Article  CAS  Google Scholar 

  • Martinez-Outschoorn UE, Lin Z, Ko YH, Goldberg AF, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP (2011) Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle 10:2521–2528

    Article  CAS  Google Scholar 

  • Ranhotra HS (2015) Estrogen-related receptor alpha and cancer: axis of evil. J Recept Signal Transduct Res 35:505–508

    Article  CAS  Google Scholar 

  • Ranhotra HS (2018) The estrogen-related receptors in metabolism and cancer: newer insights. J Recept Signal Transduct Res 38:95–100

    Article  CAS  Google Scholar 

  • Stein RA, Gaillard S, McDonnell DP (2009) Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells. J Steroid Biochem Mol Biol 114:106–112

    Article  CAS  Google Scholar 

  • Su TJ, Ku WH, Chen HY, Hsu YC, Hong QS, Chang GC, Yu SL, Chen JJW (2016) Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma. Am J Cancer Res 6:1317–1330

    CAS  PubMed  PubMed Central  Google Scholar 

  • Thewes V, Simon R, Schroeter P, Schlotter M, Anzeneder T, Buttner R, Benes V, Sauter G, Burwinkel B, Nicholson RI et al (2015) Reprogramming of the ERR alpha and ER alpha target gene landscape triggers tamoxifen resistance in breast cancer. Cancer Res 75:720–731

    Article  CAS  Google Scholar 

  • Tribollet V, Barenton B, Kroiss A, Vincent S, Zhang L, Forcet C, Cerutti C, Perian S, Allioli N, Samarut J, Vanacker JM (2016) miR-135a inhibits the invasion of cancer cells via suppression of ERRalpha. Plos One 11:e0156445

    Article  Google Scholar 

  • Tsao SW, Yip YL, Tsang CM, Pang PS, Lau VM, Zhang G, Lo KW (2014) Etiological factors of nasopharyngeal carcinoma. Oral Oncol 50:330–338

    Article  Google Scholar 

  • Vishnoi A, Rani S (2017) MiRNA biogenesis and regulation of diseases: an overview. Methods Mol Biol 1509:1–10

    Article  CAS  Google Scholar 

  • Wicki A, Mandala M, Massi D, Taverna D, Tang HF, Hemmings BA, Xue GD (2016) Acquired resistance to clinical cancer therapy: a twist in physiological signaling. Physiol Rev 96:805–829

    Article  CAS  Google Scholar 

  • Wu F, Wang JJ, Wang YF, Kwok TT, Kong SK, Wong CW (2009) Estrogen-related receptor alpha (ERR alpha) inverse agonist XCT-790 induces cell death in chemotherapeutic resistant cancer cells. Chem-Biol Interact 181:236–242

    Article  CAS  Google Scholar 

  • Yao TT, Rao QX, Liu LY, Zheng CY, Xie QS, Liang JX, Lin ZQ (2013) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer. Virol J. https://doi.org/10.1186/1743-422X-10-175

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhai S, Zhao L, Lin T, Wang W (2019) Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth. J Cell Biochem 120:6651–6660

    Article  CAS  Google Scholar 

  • Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y, He F (2012) MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. Plos One 7:e39102

    Article  CAS  Google Scholar 

Download references

Funding

This study was funded by the Science and Technology Foundation of Shenzhen (Grant No. JCYJ20180302144624391).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuo Li.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Consent for publication

All authors give the consent for the publish of this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, F., Gao, C., Wang, W. et al. miR-137/ERRα axis mediates chemoresistance of nasopharyngeal carcinoma cells. J. Cell Commun. Signal. 16, 103–113 (2022). https://doi.org/10.1007/s12079-021-00634-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12079-021-00634-2

Keywords

Navigation